Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-0.42	22.05	22.14
Graham Fair Price	16.94	22.56	19.29
PEG	-54.55	0.35	0.77
Price/Book	6.50	3.04	2.86
Price/Cash Flow	3.78	36.59	35.25
Prices/Earnings	-11.54	9.97	11.27
Price/Sales	-6.81	0.83	0.90
Price/FCF	3.78	36.59	35.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.42	0.20	0.21
Operating Margin	-24.38	0.03	0.04
ROA	26.33	0.02	0.01
ROE	0.06	0.08	20.40
ROIC	0.05	0.04	-16.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	-91.47
Dividends QOQ	0.00	< 0.005	-100.00
EBIT QOQ	0.54	-0.08	-85.76
EPS QOQ	0.15	0.28	94.65
FCF QOQ	3.10	0.10	-96.88
Revenue QOQ	0.09	0.22	141.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21.77	16.69	-23.35
Days Sales Outstanding (DSO)	5.19	3.91	-24.56
Inventory Turnover	4.13	5.39	30.46
Debt/Capitalization	0.49	0.51	4.56
Quick Ratio	0.33	0.37	14.11
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.15	17.22	6.57
Cash	4.31	5.65	31.08
Capex	-1.39	-1.81	-30.43
Free Cash Flow	1.31	1.43	9.37
Revenue	51.55	62.79	21.80
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.81	0.86	7.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.61	6.69	-12.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating